Patient symptom surveys could cut chemo drug waste
NCT ID NCT04008056
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a 34-question symptom survey filled out by patients could give doctors enough information to authorize chemotherapy preparation, potentially reducing the number of unused drug doses. 138 people with digestive cancer participated. The goal was to see if the patient's report was as good as a doctor's exam for deciding to mix the chemo drugs.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Patient Reported Outcome questionnaire
- What this could lead to
- If successful, this could reduce wasted chemotherapy drugs by using patient symptom reports to authorize treatment preparation.
- What could go wrong
- This is a small, completed study focused on process efficiency, not a new treatment. Results may not apply to other cancers or settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIGESTIVE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Nimes
Nîmes, 30029, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Quitting before the knife: which Stop-Smoking aid works best for cancer patients?
- One dose may not fit all: blood tests could tailor cancer drug dosing
- Tailored chemo doses aim to cut severe side effects in digestive cancer patients
- New drug cocktail shows promise for tough bile duct cancer
- Steroid shot during surgery may cut cancer recovery risks
- New Antibody-Drug combo targets Hard-to-Treat digestive cancers